Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1994-03-10
1995-10-31
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
424528, 540 5, 540106, 540107, 540113, A61K 3158, C07J 4300
Patent
active
054629330
ABSTRACT:
Bile acid derivatives, processes for their preparation and use as pharmaceuticals Bile acid derivatives of the formula I
REFERENCES:
patent: 2441129 (1948-05-01), Berczeller
patent: 3937815 (1976-02-01), Bruzzese et al.
patent: 4418059 (1983-11-01), Lalezari
patent: 4499020 (1985-02-01), Lalezari
patent: 4925852 (1990-05-01), Kesseler et al.
patent: 4968790 (1990-11-01), DeVries et al.
Lehninger, Principles of Biochemistry, Worth Publishers, Inc., (1982), pp. 690-691.
Ho, N. F. H., "Utilizing Bile Acid Carrier mechanisms to Enhance Liver and Small Intestine Absorption," Annals new York Academy of Sciences 110:315-329 (1987).
Fieser, L. F. and Fieser, M., Steroids, pp. 3, 53-55, 64, 77, 79, 83 (Reinhold Pub. Corp., N.Y., 1959).
Kramer Werner
Wess Gunther
Datlow Philip I.
Hoechst Aktiengesellschaft
LandOfFree
Modified bile acid conjugates, and their use as pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified bile acid conjugates, and their use as pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified bile acid conjugates, and their use as pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1772347